Related Experiment Video

Updated: Aug 17, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Treatment of congestive heart failure. Pathophysiologic and pharmacologic concepts

S R Goldsmith

    Postgraduate Medicine
    |June 1, 1987
    PubMed

    Insights

    Congestive heart failure (CHF) is a lethal condition despite advances in treatment. Prevention through reducing myocardial infarction and understanding idiopathic dilated cardiomyopathy are crucial for improving outcomes.

    Area of Science:

    • Cardiology
    • Pathophysiology
    • Public Health

    Background:

    • Congestive heart failure (CHF) is a significant health concern in Western societies.
    • Despite a decade of progress in understanding CHF pathophysiology and treatment, it remains a highly lethal disease.
    • CHF mortality rates exceed those of most cancers, underscoring the need for effective prevention strategies.

    Purpose of the Study:

    • To emphasize the critical importance of preventing congestive heart failure.
    • To highlight the need for further research into the pathophysiology of idiopathic dilated cardiomyopathy.
    • To discuss the potential for refining current therapies for CHF based on pathophysiological understanding.

    Main Methods:

    • Review of current understanding of CHF pathophysiology.
    • Analysis of treatment strategies based on known disease mechanisms.
    • Assessment of the impact of myocardial infarction on CHF incidence and damage.

    Main Results:

    • Significant advancements in understanding CHF pathophysiology and treatment design over the last ten years.
    • CHF continues to be a highly lethal condition, necessitating a strong focus on prevention.
    • Reduction in myocardial infarction incidence and damage is paramount for CHF prevention.

    Conclusions:

    • Prevention of congestive heart failure, primarily through mitigating myocardial infarction, is of utmost importance.
    • Further investigation into the pathophysiology of idiopathic dilated cardiomyopathy is required.
    • Current effective therapies for CHF can be further refined by a deeper understanding of underlying pathophysiologic principles.

    More Related Videos

    Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

    Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

    Published on: December 11, 2017

    A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs07:09

    A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

    Published on: February 18, 2022

    Related Concept Videos

    Pathophysiology of Heart Failure01:17

    Pathophysiology of Heart Failure

    Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...